These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6150246)

  • 41. Efficacy of tamoxifen as treatment of breast cancer.
    Powles TJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical study of the effectiveness of zitazonium].
    Borisov VI; Voznyĭ EK; Korobkova LI
    Sov Med; 1983; (6):39-41. PubMed ID: 6351283
    [No Abstract]   [Full Text] [Related]  

  • 43. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 44. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.
    Lippman ME; Chabner BA
    NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer.
    Rutqvist LE; Johansson H;
    Acta Oncol; 2007; 46(2):133-45. PubMed ID: 17453361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
    Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
    Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of tamoxifen in the treatment of female patients with advanced breast cancer].
    Pieńkowska F; Pieńkowski T; Siedlecki P; Zborzil J; Paszko Z; Padzik H; Rubach M
    Nowotwory; 1985; 35(2):137-44. PubMed ID: 3911172
    [No Abstract]   [Full Text] [Related]  

  • 48. A design for phase II testing of anticancer agents within a phase III clinical trial.
    Schaid DJ; Ingle JN; Wieand S; Ahmann DL
    Control Clin Trials; 1988 Jun; 9(2):107-18. PubMed ID: 3396362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of early breast cancer.
    Lancet; 1984 Nov; 2(8413):1193. PubMed ID: 6150243
    [No Abstract]   [Full Text] [Related]  

  • 50. Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?
    Strulov Shachar S; Hurria A; Muss HB
    J Clin Oncol; 2016 Oct; 34(28):3486-8. PubMed ID: 27432932
    [No Abstract]   [Full Text] [Related]  

  • 51. Multimodal therapy for stage-II breast cancer.
    Smith IE; Powles TJ
    Lancet; 1978 Dec; 2(8103):1313. PubMed ID: 82819
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomised trials: the case for science in medicine.
    Baum M
    Recent Results Cancer Res; 1988; 111():6-17. PubMed ID: 3051231
    [No Abstract]   [Full Text] [Related]  

  • 53. Screening and breast cancer.
    Verbeek AL; Hendriks JH; Holland R; Mravunac M; Sturmans F; Day NE; Collette HJ; Rombach JJ; de Waard F
    Lancet; 1984 Sep; 2(8404):690. PubMed ID: 6147706
    [No Abstract]   [Full Text] [Related]  

  • 54. Concepts and problems in the evaluation of screening programs.
    Prorok PC; Hankey BF; Bundy BN
    J Chronic Dis; 1981; 34(4):159-71. PubMed ID: 7014584
    [No Abstract]   [Full Text] [Related]  

  • 55. Consensus guidelines and clinical practice in breast cancer.
    Mittra I
    Eur J Cancer; 1991; 27(10):1331. PubMed ID: 1835607
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of duration of response: a problem of oncology trials.
    Morgan TM
    Control Clin Trials; 1988 Mar; 9(1):11-8. PubMed ID: 3356149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer: the failure of treatment.
    Haybittle JL; Freedman LS
    Br J Radiol; 1988 Feb; 61(722):173-4. PubMed ID: 3349256
    [No Abstract]   [Full Text] [Related]  

  • 58. How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.
    Gelber RD; Cole BF; Goldhirsch A
    Recent Results Cancer Res; 1993; 127():221-33. PubMed ID: 8502819
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of advanced breast cancer.
    Sinoff CL
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):803-4. PubMed ID: 6402259
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Curability of breast cancer.
    Brewin TB
    Lancet; 1975 Sep; 2(7932):457. PubMed ID: 51262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.